Previous Close | 0.0100 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.0100 |
Strike | 52.50 |
Expire Date | 2024-06-21 |
Day's Range | 0.0100 - 0.0100 |
Contract Range | N/A |
Volume | |
Open Interest | 1.87k |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).